心房颤动 (房颤 )是临床上最常见的持续性心律失常 ,也是当前心律失常治疗中最薄弱的环节。尽管最近几年 ,对房颤机制有了更深入了解 ,但在临床治疗策略上 ,除了华法林抗凝治疗以外 ,却没有大的突破。这就需要研究一些新的治疗方法并设计相应的多中心临床试验以验证其有效性 , Atrial fibrillation (AF) is the most common persistent arrhythmia in the clinic and is the weakest link in the current arrhythmia treatment. Although the mechanism of atrial fibrillation has been more thoroughly understood in recent years, no major breakthrough has been made in clinical treatment except warfarin anticoagulation therapy. This requires the study of some new treatments and design of the corresponding multi-center clinical trials to verify its effectiveness,